Effects of a structured educational intervention in moderate-to-severe elderly asthmatic subjects by Milanese, M. et al.
World Allergy Organization Journal 12 (2019) 100040Contents lists available at ScienceDirect
World Allergy Organization Journal
journal homepage: www.sciencedirect.com/journal/wao-journalEffects of a structured educational intervention in moderate-to-severe
elderly asthmatic subjects
M. Milanese a,*, S. Terraneo b, I. Baiardini c, F. Di Marco d, A. Corsico e, A. Molino f, N. Scichilone g,
on behalf of EDUCA Group
a Department of Medicine, Respiratory Unit, ASL2 Savonese, Savona, Italy
b Respiratory Unit, ASST Santi Paolo e Carlo, Milan, Italy
c Department of Internal Medicine, Respiratory Diseases and Allergy Clinic, University of Genova, Azienda Policlinico IRCCS San Martino, Genoa, Italy
d Department of Health Sciences, Universita degli Studi di Milano, Respiratory Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy
e Department of Internal Medicine and Therapeutics, Pneumology Unit, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Pavia, Italy
f Department of Respiratory Diseases, Division of Pneumology, University of Naples Federico II, Napoli, Italy
g Department of Biomedicine and Internal and Specialistic Medicine (DIBIMIS), University of Palermo, Palermo, ItalyA R T I C L E I N F O
Keywords:
Elderly
Asthma
Device misuse
EducationAbbreviations: ACT, asthma control test; EDUCA,
acting muscarinic antagonists; SAE, severe asthma e
FVC, forced vital capacity; FEV1, forced expiratory
composite score; mMRC, modified medical research
* Corresponding author.
E-mail address: manlio.milanese@unige.it (M. M
https://doi.org/10.1016/j.waojou.2019.100040
Received 24 January 2019; Received in revised for
1939-4551/© 2019 Published by Elsevier Inc. on
creativecommons.org/licenses/by-nc-nd/4.0/).A B S T R A C T
Background: Adherence to inhaled drugs is linked to patients’ satisfaction with their device, and an incorrect use
can negatively affect the outcomes of asthma treatment. We speculated that this is particularly true in elderly
asthmatic subjects.
Aim: We performed a national pre-post interventional multicentre study, enrolling moderate-to-severe asthmatic
subjects aged 65 years treated with fixed inhaled combination drugs by dry powder inhaler (DPI) or pressurized
metered dose inhaler (pMDI). Adherence and critical errors were evaluated by means of validated questionnaires
at first visit (V1) and after 3–6 months (V2). At V1, subjects underwent intensive training on the correct use of
their device by physical demonstration.
Results: A total of 411 asthmatics (F/M: 238/173, mean ageSD: 72  5 years) participated to the study. At V1,
50% of the study subjects showed an Asthma Control Test (ACT) score 19 despite GINA step 3 and 4 treatment,
and 40% had experienced at least one severe asthma exacerbation in the previous year. Poor adherence to
treatment was recorded in 43% of subjects, and at least one error in using the device was registered in 56% of
subjects. At V2, available for 318 patients, both the percentage of individuals with poor adherence and with at
least one critical error significantly decreased (from 46% to 25%, and from 49% to 25%, respectively; p < 0.001
for both comparisons) with a significant increase of the ACT score (from 19  4.9 to 20  4.0, p < 0.001).
Conclusions: Asthma in the elderly is characterized by low levels of symptom control. Educational interventions
are strongly advocated in this age group in order to increase adherence to treatment and inhaler techniques.Introduction
Errors in inhaler handling, not taken into account in clinical trials,
could impact on drug delivery and minimize treatment benefits.
Approximately 50 billion US dollars (USD) are spent annually on inhalers
in the USA, and 7 to 15 billion USD are wasted due to incorrect tech-
nique.1 Lewis et al.2 developed a model for estimating the impact of poorelderly and device use in chronic
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behalf of World Allergy Organizinhaler technique on the economic burden of asthma and COPD in Spain,
Sweden and UK, and they attributed 2.2–2.7% of direct asthma and
COPD costs of 105 million Euros to poor inhalation technique across the
three countries studied.
In a previous study, we reported a high rate of uncontrolled asthma in
elderly subjects3 with possible explanations due to the well-known poor
perception of dyspnea in the elderly4 and the occurrence ofasthma; LABA, long-acting β2 agonist; ICS, inhaled corticosteroids; LAMA, long-
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Table 1
Check list for detecting errors with the device in use (modified from ref. 22).
MDI device
Do not remove cap
Do not handle correctly
Activates before inspiring
Activates at the end of inspiration
Do not activate
Do not inspire
Inspires too quickly
Inhales nasally
DPI device
Do not remove cap
Do not charge the dose correctly
Charges the dose, but inverts the device before inhaling
Charges the dose, but shakes the device (as a MDI)
Expires (instead inspiring)
Do not connect correctly with the mouthpiece of the device
Do not inspire with proper velocity
Do not inhale orally
Inhales nasally
Is not able to understand when the device is empty
M. Milanese et al. World Allergy Organization Journal 12 (2019) 100040comorbidities; of note, low adherence to therapy or improper use of
inhaler devices, which are known to be associated with loss of asthma
control,5,6 were not explored. Among subjects with obstructive airway
diseases, only less than one quarter are compliant with their medications
(80% of prescribed doses) as reported by the Italian National Health
Agency.7 Moreover, correct use of the inhalation devices is essential to
ensure the effectiveness of the treatment,8 and a high rate of inhalation
device mishandling has been reported in younger asthmatics, with an
impact on asthma control.9–11 It is logical to hypothesize that elderly
asthmatic patients are more at risk of errors because of the higher fre-
quency of comorbid conditions potentially affecting the correct use of the
device, as recently reported by Usmani et al..12 Interestingly, a recent
meta-analysis from Maricoto et al.13 reported a significant effect of
inhaler educational programs in reducing exacerbations and in
improving clinical control, specifically in subjects aged 65 and older with
asthma or COPD. However, the authors also admitted to have failed in
the attempt to uncover important information about the role of inhaler
technique alone, due to the fact that studies included in the meta-analysis
addressed a large variety of interventional approaches, making it harder
to detect the contribution of incorrect inhaler maneuvers. Also, the ma-
jority of the studies did not control for the confounding effect of adher-
ence itself, which may be more relevant than inhaler performance.
The aim of our study was to evaluate the level of adherence and the
rate of inhaler mishandling on a cohort of elderly asthmatics, and the
effect of a structured one-visit educational intervention on asthma con-
trol assessed after a period of 3–6 months.
Methods
The EDUCA (Elderly and DeviceUse in Chronic Asthma) Study, a pre-
post interventional trial with a follow-up of 3–6 months, promoted by the
Italian Respiratory Society (IRS), was carried out between June 2016 and
June 2017 in 21 Italian Health Service Pulmonology and Allergy Clinics.
To be consecutively enrolled in the study, subjects were required to have
a physician-diagnosis of asthma based on the 2016 GINA guide,14 be 65
yrs of age or older and using a combination of Long-Acting Beta-2 Ago-
nists (LABA) and Inhaled Corticosteroids (ICS) in a fixed dose single
device or in two different devices. As by GINA 201614 tiotropium was
considered off-label for asthma, patients under treatment with tio-
tropium or another Long Acting Muscarinic Antagonist (LAMA) were
excluded from enrollment. Data were recorded by researchers using a
standardized questionnaire which included: 1) age, sex, height, weight;
2) smoking habit; 2) educational level; 3) the number of severe asthma
exacerbations (SAEs) in the previous year, defined as “an asthma exac-
erbation requiring systemic corticosteroids for at least three days and/or
hospitalization”15; the device or devices in use (with the exception of that
for rescue medication, i.e. salbutamol); the daily ICS dosage expressed as
low, medium, or high dosage of beclomethasone dipropionate CFC or
equivalent according to GINA classification14; concomitant drugs for
other diseases (arterial hypertension, chronic heart disease, diabetes,
gastroesophageal reflux, osteoporosis) and the presence or arthritis on
hands. In addition, the following Patient-Reported outcomes (PROs)
were assessed by validate tools a) dyspnea (modified Medical Research
Council (mMRC) dyspnea scale,16 b) level of asthma control (Asthma
Control Test ACT),17 c) health status (SF 12),18 d) adherence to treatment
(Morinsky Medication Adherence Scale),19 and e) anxiety and depression
(Hospital Anxiety Depression Scale, HADS).20
At each visit, patients underwent a Forced Vital Capacity (FVC) ma-
neuver according to the standardized technique21 after proper wash-out
period from bronchodilator drugs. At the end of the visit, patients were
asked to use their device, and their maneuvers were analyzed following
the check-list reported in Table 1, modified from the Inhaler Error
Steering Committee Document22 which we adopted when the study was
designed. Whenever applicable, patients were immediately informed
about their errors and re-checked until adequately instructed to handle
correctly their device by physical demonstration.2The study was approved by the Coordinating Ethic Committee of
Palermo, Italy, and a written informed consent was collected locally for
each patient.
Data analysis
Data from each center were centralized to the investigators of Pavia,
Italy (AMC), who were responsible for data quality control, and then
submitted to the center of Milano, Italy (FDM and ST) for statistical
analysis. The results are shown as mean  standard deviation (SD), un-
less otherwise stated.
Lilliefors corrected K–S test was performed before the data analysis in
order to examine the distribution of the residuals of the parametric tests.
For continuous variables, two tailed paired t-test analysis was used to
analyze the difference between first and second visit in terms of errors
done with the device in use, ACT, mMRC and SF12. Unpaired Student's t-
test analysis (test for equal variances) was used for comparisons between
patients for continuous variables; for dichotomous variables Chi square
or Fisher's exact test were used, as appropriate.
Variables that resulted in p values < 0.15 were used in a multivariate
logistic regression model to predict factors that were associated with at
least one error in the use of inhaler. The odds ratios (OR) and their 95%
confidence intervals were also derived. All tests were two-sided, and p <
0.05 were considered statistically significant. Asthma control was
defined as optimal, partially or poorly controlled for ACT score 20,
16–19, or 15, respectively.23 Statistical tests were performed using the
Statistical Package for Social Sciences (version 21.0; SPSS, Chicago, IL).
Results
A total of 452 asthmatic subjects were enrolled and 411 subjects were
retained for the statistical analysis as 41 were excluded, a) because under
treatment with LAMA, b) for inconsistency of therapy between visit 1 and
2, and c) inclusion criteria not respected (i.e. age <65 years).
Table 2 summarizes demographic, clinical and functional data of the
subjects. The number of females was higher than that of males, and an
ACT score 19 occurred in 49% of the subjects, with at least one SAE in
40% of them. The devices in use were a pMDI in 41% and a DPI in 59% of
subjects, the latter represented by Diskus (39%), Turbohaler (31%),
Nexthaler (17%) and Ellipta (13%). The second device in use, not
including salbutamol as rescue medication, was reported in a negligible
percent of patients (36 patients, 9% of the whole population), in whom a
non-fixed LABA/ICS combination was the option. During the first clinical
evaluation (V1), at least one error was reported in 56% of the subjects,
and a low adherence was detected in 43% of them. At least one comor-
bidity was present in 80% of the subjects, and more than a quarter (30%)
of them suffered from hand arthritis. HADS score was 7 4 and 8 4 for
Table 2
Demographic, clinical and functional data of the study subjects.
All patients (n ¼ 411)
Age, yrs 72  5
Male/female, n (%) 173 (42)/238 (58)
BMI, kg/m2 27  5
BMI30, n (%) 89 (22)
Smoke History
Current/former/no smoke, n (%) 26(6)/147(36)/236 (57)
Pack-years 18  17
>20 P/Y, n (%) 46(37)
Subjects with SAE, n (%) 167 (40)
Education
Primary School, n (%) 113(29)
Secondary, n (%) 149(37)
High school, n (%) 105(26)
Degree, n (%) 31(8)
Lives alone, n (%) 72 (17%)
mMRC, (median, IQR) 1(1,2)
ACT, score 19  4.7
ACT19, n (%) 197 (49)
FEV1, % predicted 80  24
Comorbidity, n (%) 334 (81)
Hand Arthritis, n (%) 113(30)
Clinically relevant depression, n (%) 81(20)
Clinically relevant anxiety, n (%) 129(31)
Morinsky, score 1.03  0.96
Data are expressed ad mean standard deviation if not otherwise stated. mMRC:
modified Medical Research Council dyspnea score; SAE, Severe Asthma Exacer-
bation. ACT: Asthma Control Test; Comorbidity: any of gastroesophageal reflux,
arterial hypertension, osteoporosis, heart disease; IQR: interquartile range.
Clinically relevant depression/anxiety: evaluated with HADS scale.
M. Milanese et al. World Allergy Organization Journal 12 (2019) 100040anxiety and depression, clinically relevant in 20% and 31% of the pa-
tients enrolled, respectively.
Effect of training on the correct use of device (Table 3)
During follow-up visit (Visit 2), both the percentage of patients with
poor adherence and that of patients who committed at least one error
decreased significantly (p < 0.001), from 40% to 23% and from 52% to
23%, respectively. A significant reduction in the percentage of at least
one error was reported also in the subset of patients with clinically
relevant anxiety or depression. A parallel clinically significant increase ofTable 3
Effects of educational training on outcome variables (N ¼ 318 patients).
Visit 1 Visit 2 Mean  SD
(95% CI)
p value
Error, n 0.74 
1.02
0.38 
0.56
0.37  0.88
(0.26–0.47)
<0.001
Error 1, n (%)
 All patients 167 (52) 102 (32) <0.001
 Patients with clinically
relevant anxiety or
depression at visit 1
74 (66) 49 (42) <0.001
Low Adherence, n (%) 130 (41) 74(23) <0.001
SF-12
PCS 38.90 
10.36
40.16 
10.21
1.27  7
(0.48–2.05)
<0.001
MCS 48.03 
10.92
50.73 
10.07
2.69  7.96
(1.81–3.58)
<0.005
ACT 18.85 
4.88
20.32 
4.04
1.46  3.02
(1,13–1,79)
<0.001
mMRC 1.33 
0.99
1.09 
0.88
0.24  0.63
(0.17–0.31)
<0.001
Data are expressed and mean  standard deviation if not otherwise stated.
mMRC: modified Medical Research Council dyspnea score; SF12: Short Form
Health Survey; PCS: Physical Health Composite Score; MCS: Mental Health
Composite Score; ACT: Asthma Control Test; SD: standard deviation. p< 0.050 in
bold. Two tailed paired t-test analysis for continuous variables and Chi square
test for dichotomous variables.
31.46 3.02 (95%CI: 1.13–1.79, p< 0.001) was also observed in the ACT
score (from 18.85  4.88 to 20.32  4.04).
Correlation between errors and asthma outcomes
Differences between subjects with at least one error and without any
error are described in Table 4. Variables that were significantly associ-
ated with errors were used in a multivariate logistic regression model to
identify independent factors able to predict critical errors in the use of
inhaler. As shown in Table 5, comorbidities, a low educational status and
the presence of an asthma exacerbation in the last six months were fac-
tors independently associated to commit at least one error with the
device.
Discussion
The main findings of our study are that in a large cohort of elderly
moderate to severe asthmatics half of them had features of uncontrolled
disease despite optimal treatment, and that a similar proportion of sub-
jects were poor adherents to treatment and misused their device. In this
context, a one-visit educational training was shown to improve symptom
control and adherence to inhaled therapy in subjects with at least one
error in the use of their inhaler.
The current findings are in line with the well-known poor control of
asthma in the elderly.24 It is noteworthy that our subjects had uncon-
trolled asthma despite having been prescribed optimal treatment ac-
cording to GINA guidelines. Potential explanations for the lack of asthma
control in our cohort of elderly patients could be the well-known poor
perception of dyspnea in the elderly,25 and low level of adherence to
therapy or improper use of inhaler devices.5,6 The reason for the
increased adherence at the follow-up visit in the absence of a specific
intervention promoting adherence could lie in the well-recognized bias,
the Hawthorn effect, originally described in an industrial setting.26 This
suggests that the subjects' behavior may be modified by the subjects’
awareness that they are being studied and for which they receive addi-
tional attention.
Poor technique has been associated with age, sex, educational level
and emotional problems.27 In asthma, device-handling errors have
already been described, as well as their association with poor disease
control.10,20–30 A high rate of inhalation device mishandling has been
reported in younger asthmatics, with an impact on asthma control.11,31 In
elderly COPD patients, high rates of inhaler device mishandling and their
potential impact on COPD on exacerbation were recently described by
Molimard et al.,32 where an underestimation of handling errors of device
(>50% of the subjects) was associated with an increased rate of severe
exacerbations (Odds Ratio of 1.86). Moreover, data on elderly asthmatic
populations are lacking, although Melani et al.10 reported a significant
association between inhaler mishandling and older age.
Recently, educational interventions of inhaler technique were
reviewed33 and found to be effective, at least on the short-term (with an
average follow-up of 5 months). The authors concluded that, as expected,
effectiveness of interventions holds true for patients with an insufficient
inhaler technique, whereas interventions may be less valuable for pa-
tients with an already moderate to good technique. Therefore, consid-
ering constrains on budget available and time available, they suggested
to pursue an educational intervention only in those in whom errors were
documented, as in the present study. A recent Cochrane review on in-
terventions to improve inhaler technique34 concluded that confirmatory
trials are required, as the maximum duration of follow-up was only 26
weeks. Ideally, studies should report all critical descriptive statistics, and
inhaler technique should be checked by persons blinded to group allo-
cation. Also, the authors suggest to focus efforts on poor controlled
asthma and/or on poor inhaler technique. Very recently, Maricoto et al.13
carried out a systematic review and meta-analysis on studies conducted
in older subjects, specifically addressing the role of education on inhaler
technique on disease control and exacerbation rates. Although the
Table 5
Significant univariate and multivariate logistic regression analyses of predictors
for at least one error in the use of the inhaler.
Variable
UNIVARIATE MULTIVARIATE
OR 95% CI p* OR 95%CI p**
Lower education 1.97 1.30–3.01 0.001 1.77 1.13–2.77 0.012
SAE 3.29 2.13–4.97 <0.001 2.84 1.82–4.43 <0.001
Comorbidity 2.67 1.60–4.47 <0.001 2.46 1.39–4.34 0.002
Hands arthritis 1.16 0.75–1.82 0.493 – – –
Poor adherence
to therapy
1.37 0.92–2.04 0.111 – – –
Clinically
relevant
anxiety
2.22 1.43–3.43 <0.001 1.28 0.75–2.19 0.352
Clinically
relevant
depression
2.49 1.46–4.25 0.001 1.78 0.94–3.39 0.076
p < 0.05 in bold.
*Binomial Logistic Regression Analysis for univariate analysis.
**Multiple Regression Analysis for multivariate analysis.
Table 4
Characteristics of enrolled patients according to the presence of at least one error in the use of inhaler.
Without any error
N ¼ 181
With at least one error
N ¼ 230
mean (95%CI) OR (95%CI) p value
Age, yrs 72  5 72  6 0,74
(1.82–0.32)
0.171
Gender, female, n (%) 74 (43) 92 (41) 1.16 (0.75–1.61) 0.613
Higher educationa, n (%) 74 (43) 62(27) 0.50 (0.33–0.76) 0.001
Living alone, n (%) 30(17) 43(19) 1.18 (0.70–1.98) 0.600
Poor adherence to therapyb, n (%) 130 (56) 49(27) 3.05 (2.30–5.30) <0.001
SAE 1, n (%) 46(25) 121 (53) 3.36 (2.18–5.17) <0.001
Comorbidity, n (%) 132 (73) 202 (87) 2.41 (1.40–4.13) <0.001
BMI  30 Kg/m2 53(30) 567 (30) 1 (0.65–1.57) 0.810
Rhinitis, n (%) 106 (62) 114 (50) 0.63 (0.42–0.94) 0.026
DPI, n (%) 105 (58) 137 (60) 1.09 (0.74–1.61) 0.687
MDI, n (%) 76 (42) 93 (40) 0.92 (0.62–1.36) 0.687
Clinically relevant anxiety, n (%) 40(22) 89 (39) 2.22 (1.4–3.43) <0.001
Clinically relevant depression, n (%) 22(12) 59(26) 2.49 (1.46–4.25) 0.001
p < 0.05 in bold,  unpaired Student's t-test analysis for continuous variables, Chi square test for dichotomous variables, binomial logistic regression to calculate odds
ratio for dichotomous variables.
a From high school.
b Evaluated with Morinsky scale; SAE: Severe Asthma Exacerbation.
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the rate of exacerbations in older individuals, the heterogeneity of the
included studies did not allow to assess the contribution of improved
inhaler technique education alone. Taken together, these observations
advocate for future studies specifically designed to compare different
educational interventions on clinical outcomes in vulnerable pop-
ulations, such as older asthmatics. From a clinical standpoint, providing
the most suitable and efficacious time interval for regular follow-up is the
main challenge.
The presence of comorbidities has been demonstrated to influence
quality of life in adults with asthma,35 which in turn can affect adherence
to treatment. In this context, specific comorbidities, such as arthritis, may
also impair the ability to use inhalation devices.
Some limitations should be considered in the interpretations of our
results. First, this is an open (not blinded) study, with the lack of a
control group and, as such, both patients' behaviors and researchers'
judgements could have been influenced to some extent. However, the
collection of the items in a single database and the analysis of the data
were conducted by two independent teams. Second, the results are
limited to a very short period of observation and cannot be extrapolated
to longer lengths of time: the 6 months effects on adherence due to the
targeted intervention may potentially vanish afterwards as expected by
findings from other real-life studies on duration of adherence. Third, the4educational action was conducted during outpatient visits by well-
trained pulmonologists and allergists, which may have affected the
outcomes. Moreover, one can observe that not all errors are similar. For
example, failure to remove the inhaler cap is a critical error, as opposed
to failure to hold the inhaler upright. However, the document of the
Inhaler Error Steering Committee22 did not distinguish between these
two types of error and defined as critical an error “when a patient
performs an error, displays imperfect technique or lacks knowledge on
usage or maintenance of the inhaler device that is likely to significantly
impair the delivery of adequate medication on all occasions”. However,
recently Price et al.36 were able to identify in the CRITIKAL Study which
errors are critical, meaning that they negatively impact on asthma
outcomes. In our study, the most frequent error for the MDI device was
“activating before inspiring” (36%), and for DPI “not inspiring with
proper velocity” (32%), both of which were demonstrated to be corre-
lated with uncontrolled asthma in the CRITIKAL study.36 Also
“inspiring too quickly” (25%), “not handling correctly (16%) and
“activating at the end of inspiration” for MDI, were judged as critical in
the study by Price et al.36
In conclusion, we found that a one-visit targeted educational inter-
vention may enhance asthma control in the elderly, presumably by
increasing adherence to treatment and inhaler techniques. The inter-
vention is effective also in patients with clinically relevant anxiety and
depression, which have been associated to a lower confidence in device
usage.37 A check-list for potential critical errors may be helpful to iden-
tify the subjects candidates to educational efforts.
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